WHO expert committee on specifications for pharmaceutical preparations: thirty-ninth report by unknown
Rev. Inst. Med. trop. S. Paulo
48(3):134, May-June, 2006
*This book is available at the Library of the Instituto de Medicina Tropical de São Paulo
BOOK REVIEW*
WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS. Thirty-ninth Report.  Geneva, World Health
Organization, 2005. 142p. ilus.  (WHO Technical Report Series 929).   ISBN 92 4 120929 1
This report presents the recommendations of an international group
of experts convened by the World Health Organization to consider
matters concerning the quality assurance of pharmaceuticals and
specifications for drug substances and dosage forms. Important topics
were addressed, such as regulatory guidance on interchangeability of
medicines, fix-dose combinations: how to regulate them, new guidance
in the area of good manufacturing practices (GMP) and stability testing
and counterfeit medicines. In addition some 12 new monographs for
antiretrovirals, 6 new ones on TB drugs, including 2-, 3- and 4-fixed-
dose preparations, as well as monographs for anti-malarial medicines
are discussed in detail. Seven new specifications for antiretrovirals
were adopted.
The report also includes newly International Chemical Reference
Substances for the series of artemisinin derivatives. The following new
WHO guidelines were adopted and are annexed to the report: GMP:
requirement for the sampling of starting materials, (amendment to
current text), GMP: water for pharmaceutical use, guideline for
sampling of pharmaceuticals and related materials, guidelines for
registration of fixed-dose combination medicinal products.
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